利德曼: 董事会决议公告

Core Viewpoint - The board of directors of Beijing Lideman Biochemical Co., Ltd. has approved the 2025 semi-annual report, confirming that it accurately reflects the company's actual situation without any false statements or omissions [1][2]. Group 1 - The sixth board of directors held its fifth meeting on August 26, 2025, via telecommunication, with all necessary notifications sent to the board members [1]. - The meeting was attended by all seven directors, and the presence of supervisors and senior management was noted, ensuring compliance with relevant laws and regulations [1]. - The board unanimously approved the proposal regarding the full and summary report for the first half of 2025, with a voting result of 7 votes in favor, 0 against, and 0 abstentions [2]. Group 2 - The company asserts that the 2025 semi-annual report and its summary were prepared in strict accordance with applicable laws, regulations, and guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange [1]. - The report is claimed to be true, accurate, and complete, reflecting the company's actual conditions without any misleading statements or significant omissions [1].